A detailed history of Wells Fargo & Company transactions in Annexon, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 218,214 shares of ANNX stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
218,214
Previous 150,616 44.88%
Holding current value
$1.43 Million
Previous $738,000 74.93%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.49 - $7.2 $303,515 - $486,705
67,598 Added 44.88%
218,214 $1.29 Million
Q2 2024

Aug 13, 2024

BUY
$4.33 - $6.79 $527,008 - $826,417
121,711 Added 421.07%
150,616 $738,000
Q1 2024

May 10, 2024

BUY
$4.03 - $7.81 $50,266 - $97,414
12,473 Added 75.91%
28,905 $207,000
Q4 2023

Feb 09, 2024

BUY
$1.63 - $4.63 $8,498 - $24,140
5,214 Added 46.48%
16,432 $74,000
Q3 2023

Nov 13, 2023

SELL
$2.13 - $3.84 $13,127 - $23,665
-6,163 Reduced 35.46%
11,218 $26,000
Q2 2023

Aug 15, 2023

BUY
$2.1 - $6.37 $35,918 - $108,952
17,104 Added 6174.73%
17,381 $61,000
Q1 2023

May 12, 2023

BUY
$3.74 - $7.46 $18 - $37
5 Added 1.84%
277 $1,000
Q4 2022

Feb 13, 2023

BUY
$4.56 - $6.61 $27 - $39
6 Added 2.26%
272 $1,000
Q3 2022

Nov 14, 2022

BUY
$3.75 - $6.63 $348 - $616
93 Added 53.76%
266 $2,000
Q2 2022

Aug 12, 2022

SELL
$2.11 - $4.06 $5,625 - $10,823
-2,666 Reduced 93.91%
173 $1,000
Q1 2022

May 16, 2022

SELL
$2.73 - $11.94 $30,529 - $133,525
-11,183 Reduced 79.75%
2,839 $8,000
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $159,837 - $306,042
13,911 Added 12532.43%
14,022 $161,000
Q2 2021

Aug 16, 2021

SELL
$17.81 - $27.48 $67,891 - $104,753
-3,812 Reduced 97.17%
111 $2,000
Q1 2021

May 13, 2021

SELL
$22.0 - $35.01 $171,688 - $273,218
-7,804 Reduced 66.55%
3,923 $109,000
Q4 2020

Feb 09, 2021

BUY
$20.81 - $30.55 $13,797 - $20,254
663 Added 5.99%
11,727 $294,000
Q3 2020

Nov 05, 2020

BUY
$17.5 - $30.23 $193,620 - $334,464
11,064 New
11,064 $334,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $312M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.